These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33409135)

  • 21. Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
    Wehrhan F; Gross C; Creutzburg K; Amann K; Ries J; Kesting M; Geppert CI; Weber M
    J Transl Med; 2019 Mar; 17(1):69. PubMed ID: 30832685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ).
    Pichardo SEC; van der Hee JG; Fiocco M; Appelman-Dijkstra NM; van Merkesteyn JPR
    Br J Oral Maxillofac Surg; 2020 Sep; 58(7):771-776. PubMed ID: 32631756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication-related Osteonecrosis of the Jaw: A Review.
    AlDhalaan NA; BaQais A; Al-Omar A
    Cureus; 2020 Feb; 12(2):e6944. PubMed ID: 32190495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
    Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
    Gross C; Weber M; Creutzburg K; Möbius P; Preidl R; Amann K; Wehrhan F
    J Transl Med; 2017 Jun; 15(1):128. PubMed ID: 28587628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation.
    Inchingolo F; Cantore S; Dipalma G; Georgakopoulos I; Almasri M; Gheno E; Motta A; Marrelli M; Farronato D; Ballini A; Marzullo A
    J Biol Regul Homeost Agents; 2017; 31(3):811-816. PubMed ID: 28958140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteonecrosis of the Jaw in the Absence of Antiresorptive or Antiangiogenic Exposure: A Series of 6 Cases.
    Aghaloo TL; Tetradis S
    J Oral Maxillofac Surg; 2017 Jan; 75(1):129-142. PubMed ID: 27569557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Choosing the Right Partner for Medication Related Osteonecrosis of the Jaw: What Central European Dentists Know.
    Bruckmoser E; Palaoro M; Latzko L; Schnabl D; Neururer SB; Laimer J
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33922326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dentists' knowledge about medication-related osteonecrosis of the jaw and its management.
    Al-Eid R; Alduwayan T; Bin Khuthaylah M; Al Shemali M
    Heliyon; 2020 Jul; 6(7):e04321. PubMed ID: 32760820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for dental findings of the development of medication-related osteonecrosis of the jaw: Investigation of 3734 teeth in cancer patients receiving high dose antiresorptive agents.
    Otsuru M; Fujiki Y; Soutome S; Nakamura N; Miyoshi T; Naruse T; Ohnuma M; Hotokezaka Y; Rokutanda S; Umeda M
    J Dent Sci; 2024 Jan; 19(1):203-210. PubMed ID: 38303840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan.
    Shibahara T
    Jpn Dent Sci Rev; 2019 Nov; 55(1):71-75. PubMed ID: 30949254
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Reinert CP; Pfannenberg C; Gatidis S; la Fougère C; Nikolaou K; Hoefert S
    Front Oncol; 2021; 11():700397. PubMed ID: 34277447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Awareness and practice of dentists in gulf cooperation council countries regarding medication-related osteonecrosis of the jaw - A web-based survey.
    Nassani MZ; Tarakji B; Alqahtani AM; Alali FM; Noushad M; Rastam S; Alsalhani AB; Alfadel MK; Alzuabi AA; Ateen AM; Khojah AB; Zaman MU; Alqahtani AS; Alqhtani NR; Nabhan AB; Alhedyan FS; Kujan O; Al-Maweri SA
    J Dent Sci; 2023 Oct; 18(4):1677-1684. PubMed ID: 37799864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medication--related osteonecrosis of the jaws. The first reported cases in the Baltic States and a literature review.
    Zaleckas L; Stacevičius M; Proškutė D; Povilaitytė J
    Stomatologija; 2015; 17(3):89-96. PubMed ID: 26879401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medication-related osteonecrosis of the jaw: Clinical and practical guidelines.
    Rosella D; Papi P; Giardino R; Cicalini E; Piccoli L; Pompa G
    J Int Soc Prev Community Dent; 2016; 6(2):97-104. PubMed ID: 27114946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current knowledge regarding medication-related osteonecrosis of the jaw among different health professionals.
    Miranda-Silva W; Montezuma MA; Benites BM; Bruno JS; Fonseca FP; Fregnani ER
    Support Care Cancer; 2020 Nov; 28(11):5397-5404. PubMed ID: 32144584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication-Related Osteonecrosis of the Jaws (MRONJ) in Children and Young Patients-A Systematic Review.
    Rosales HD; Garcia Guevara H; Requejo S; Jensen MD; Acero J; Olate S
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
    Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of antiresorptive drugs and medication-related osteonecrosis of the jaw in nononcologic immunosuppressed patients: A systematic review.
    Sacco R; Woolley J; Yates J; Calasans-Maia MD; Akintola O; Patel V
    J Res Med Sci; 2021; 26():23. PubMed ID: 34221052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detecting the earliest radiological signs of bisphosphonate-related osteonecrosis.
    Devlin H; Greenwall-Cohen J; Benton J; Goodwin TL; Littlewood A; Horner K
    Br Dent J; 2018 Jan; 224(1):26-31. PubMed ID: 29192692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.